Published • loading... • Updated
Sky Labs Signs Exclusive Distribution Agreement with Otsuka Pharmaceutical for 'CART BP pro' in Japan
- Sky Labs Inc. announced an exclusive distribution agreement with Otsuka Pharmaceutical Co., Ltd. for 'CART BP pro' in Japan's hospital and clinic market.
- The partnership aims to broaden patient access and accelerate 'CART BP pro' adoption across Japan's healthcare facilities.
- CART BP pro, approved in 2023, helps manage hypertensive patients using photoplethysmography technology to measure blood pressure without a cuff.
- Jack Byunghwan Lee, CEO of Sky Labs, emphasized the company's commitment to validating its technology in the global market.
Insights by Ground AI
43 Articles
43 Articles
Sky Labs Signs Exclusive Distribution Agreement with Otsuka Pharmaceutical for 'CART BP pro' in Japan
Secures distribution agreement to launch CART BP pro in the Japanese hospital and clinic market- Leveraging proven technology with adoptions in 1,700+ medical institutions and national health insurance coverage in Korea SEOUL, South Korea, Feb. 5, 2026 /PRNewswire/ -- Sky Labs Inc. (CEO Jack Byunghwan Lee) announced on the 5th that it has entered into an exclusive distribution agreement with Otsuka Pharmaceutical Co., Ltd. (Otsuka) for the ring-…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources43
Leaning Left4Leaning Right3Center17Last UpdatedBias Distribution71% Center
Bias Distribution
- 71% of the sources are Center
71% Center
L 17%
C 71%
12%
Factuality
To view factuality data please Upgrade to Premium

















